Regaining Control of the Cell Cycle With CDK 4/6 Inhibitors: A Promising Targeted Therapy for Breast CancerByNeelima Vidula, MDSeptember 22nd 2014Therapies targeted to tumor biology hold the promise of improved outcomes for patients with breast cancer.